Munich, Germany

Robert Van Der Burgh

This inventor holds 1 USPTO granted patent. Top assignee: Proteros Biostructures Gmbh. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Van Der Burgh

Introduction

Robert Van Der Burgh is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biochemistry, particularly in the area of nucleosome substrate assays. His work focuses on understanding the interactions between proteins and nucleosomal substrates, which are crucial for various biological processes.

Latest Patents

Robert Van Der Burgh holds a patent for "Nucleosome substrate assays." This invention relates to methods for determining a binding and/or functional interaction of a protein of interest with a nucleosomal substrate. Notably, at least one of the histone types of the nucleosomal substrate has a homogenous post-translational modification pattern. The invention also encompasses nucleosomal substrates with similar characteristics and methods for providing such substrates.

Career Highlights

Robert is associated with Proteros Biostructures GmbH, a company that specializes in structural biology and drug discovery. His work at Proteros has allowed him to explore innovative solutions in the field of protein interactions and nucleosome research.

Collaborations

One of his notable coworkers is Adrian Schomburg, with whom he has likely collaborated on various projects related to their research interests.

Conclusion

Robert Van Der Burgh's contributions to the field of biochemistry through his patent on nucleosome substrate assays highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence research in protein interactions and structural biology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…